In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...

The US Food and Drug Administration (FDA) has approved Novavax's Covid-19 vaccine, Nuvaxovid, but only for limited use in ...

The U.S. FDA approved Novavax's COVID-19 vaccine with conditions, allowing use for people 65 and older and those 12-64 with ...

The Food and Drug Administration has approved the Novavax COVID-19 vaccine—with strict conditions. Coming after four years of clinical trials, the vaccine will only be available for older adults and ...

1 vaccine and maybe other branch vaccines against ... And this isn't specific to Novavax, just in general. Are the authorities saying, hey, well, there needs to be a full-blown efficacy study ...